The US FTC clears merger of medical device companies subject to divestments (Stryker / Wright Medical Group)

FTC Requires Medical Device Companies Stryker Corp. and Wright Medical Group N.V. to Divest Assets to Preserve Competition* The Federal Trade Commission will require medical device companies Stryker Corp. and Wright Medical Group N.V. to divest all assets related to Stryker’s total ankle replacements and finger joint implant products to remedy concerns that Stryker’s proposed $4 billion acquisition of Wright will harm competition in those markets. Under the terms of the consent agreement, the companies will divest Stryker’s total ankle replacements and finger joint implants businesses to DJO

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

US Federal Trade Commission, The US FTC clears merger of medical device companies subject to divestments (Stryker / Wright Medical Group), 3 November 2020, e-Competitions Merger Remedies, Art. N° 97754

Visites 127

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues